europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

Recombinant DNA in fermentation products is of no regulatory relevance

13/07/2022
OTHER
Recombinant DNA in fermentation products is of no regulatory relevance

(Alexandra Lensch, Elke Duwenig, Hans-Georg Dederer, Sirpa O. K¨arenlampi, Ren´e Custers, Agnes Borg, Markus Wyss)

ABSTRACT

A large variety of fermentation products are used in food and feed production, but also in other industries, and many of these products are produced with genetically modified microorganisms (GMMs).

In food and feed production, prominent examples are amino acids, vitamins, food and feed enzymes, colorants, non-caloric sweeteners, human milk oligosaccharides, or vegan alternatives of dairy, egg and meat products.

From a regulatory perspective, fermentation products are typically produced under containment. This means that premises, equipment and work processes need to be designed to prevent or at least minimize release of GMMs into the environment. The fermentation products themselves should not contain any live cells of the GMM.

Over the past years, there have been concerning developments, particularly in the European Union, stipulating that also absence of recombinant DNA might be interpreted as a regulatory requirement for fermentation products produced with GMMs.

In this paper, we attempt to place these developments into the historical context, sketch the potential negative repercussions for the food and feed industries, elaborate on the safety of recombinant DNA, and postulate that recombinant DNA should remain an integral part of the safety assessment of fermentation products but should not be misconstrued as a criterion for regulatory classification of products of biotechnology.

Read the full article below.

Recombinant DNA in fermentation products is of no regulatory relevance


Download
2022_07_IB_Article_rDNA-in-fermentation-products-is-of-no-regulatory-relevanceDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

28/02/2023

How do we live in a bioeconomy? EuropaBio at the Swedish EU Council Presidency conference


Read more
23/02/2023

EuropaBio Response to Public Consultation on Horizon Europe – interim evaluation


Read more
17/02/2023

Inter-association letter to raise our concern about the proposed definition of “natural polymers” in the REACH restriction of microplastics


Read more
01/02/2023

Joint Statement: The Data Act is a leap into the unknown


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies